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Aim Eastern Europe experienced epidemic levels of syphilis after the 
collapse of the Soviet Union. Presently data are less comprehensive 
outside the European Union (EU) and European Free Trade Asso-
ciation (EFTA). This review aims to identify published papers with 
suitable data to estimate a regional burden of disease for syphilis in 
the 19 member countries of Eastern Europe.
Methods A systematic literature review was conducted to identify 
published data relating to syphilis incidence in Eastern Europe 
through Web of Knowledge, PubMed and Google Scholar databases 
in addition to the latest surveillance report from the European Cen-
ter for Disease Prevention and Control. A total of 381 papers fitted 
our search criteria; 30 papers were subjected to full text analysis.
Results Seven papers were included in this study and provided use-
able data for 13 out of 19 member countries. There was a high level 
of heterogeneity observed in the incidence rates from the member 
countries. Gross, population weighted and geographically subdivid-
ed incidence rate estimates were carried out but the comprehensive-
ness of some of the included data is doubtful.
Conclusions Despite the limits of the data, the incidence of syphilis 
in Eastern Europe is still substantially larger than that observed in 
the EU15 countries. This indicates that efforts to control syphilis in 
Eastern Europe can be enhanced; however, such goals would require 
significant investment in infrastructure, technology and surveillance 
mechanisms.
Syphilis is a sexually transmitted disease caused by the bacterium Trepo-
nema pallidum pallidum [1]. If untreated the disease can cause mortality of 
>60% of cases, mainly due to the complications in the tertiary phase of 
the disease. Also important is vertical transmission, known as congenital 
syphilis that is associated with increased pregnancy failure rates and se-
vere birth defects. Syphilis rates in Eastern Europe increased dramatically 
after the collapse of the Soviet Union (USSR), linked to changes in health 
infrastructure, sexual behavior and the emergence of the HIV/AIDS pan-
demic [2]. As a notifiable disease in Eastern Europe, syphilis is subject to V
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surveillance reports, however the most recent review of the 
topic presented data only until 2005 [2].
Globally, the incidence of syphilis is an estimated 12 mil-
lion new cases annually and WHO estimates that the ma-
jority of new syphilis cases are in Southern Asia and Sub-
Saharan Africa. The effects of syphilis are far reaching, as 
an estimated 6.2% and 9.7% of global neo-natal deaths and 
stillbirths respectively are caused by untreated maternal 
syphilis. There are several controversies regarding syphilis 
globally. Such as, debate of what extent men who have sex 
with men (MSM) and HIV infected individuals influence 
infection dynamics. It was recently shown that MSM had 
a 140 times greater prevalence than their heterosexual 
counterparts in New York City and a separate study report-
ed a 77 times greater prevalence of syphilis in those infect-
ed with HIV [3]. Furthermore, as the causative agent can-
not be cultured or genetically manipulated, it is unclear 
what, if any, drug resistance is present globally and also 
how HIV co-infection affects the clinical manifestations of 
the disease is yet unclear [1]. Within Europe, strong sur-
veillance data are available within the European Union 
(EU) community, however out with the economic area sur-
veillance is commonly on a case notification basis that has 
been criticized for its accuracy [2]. As such, estimating the 
burden of disease regionally is more problematic.
This review is aimed at estimating a regional burden of 
syphilis in Eastern Europe. The data extracted from the 
chosen papers will be standardised to achieve a mean inci-
dence per 100 000 people per year. These rates will then 
be combined to provide an estimated regional burden and 
a population weighted regional burden of disease based on 
the standardised incidences of all 7 studies. As syphilis 
rates have previously been markedly different between 
countries this review will also provide an adjusted estimate 
based on the geographical subdivision of Eastern Europe 
into 4 regions to compliment the gross and weighted esti-
mates (Figure 1).
METHODS
Search strategy
The following databases were searched (Figure 2):
1)   Web of Knowledge – 2000 onwards, using topic search 
terms “Syphilis and “Eastern Europe” or specific country 
name;
2)   PubMed – 2000 onwards, using title/abstract search 
terms “Syphilis and “Eastern Europe” or specific country 
name;
3)   Google Scholar Medical Database – 2000 onwards, us-
ing title search terms “Syphilis and “Eastern Europe” or 
specific country name.
Specific country name included all 19 countries included in 
study separated by Boolean operator ‘OR’. As Google Schol-
ar has no keyword search, a title search was performed.
Inclusion criteria
The papers resulting from our search strategy (n = 381) 
were first screened by title, with potentially suitable papers 
having their abstracts screened for any suitable data regard-
ing syphilis (eg, new cases, incidence rates or epidemio-
logical trends). Papers which excluded significant popula-
tion  demographics  (eg,  prison  populations)  or  only 
included parts of the population (eg, blood donors, sex 
workers or young people) were excluded due to the inher-
ent bias and the effect this may have on the published data 
were compared to the incidence for the population as a 
whole. Furthermore, papers only reporting epidemiologi-
cal data for certain forms of the disease (eg, congenital 
syphilis) were also excluded as total syphilis incidence can-
not be inferred from this data. Single studies or surveillance 
reports were treated preferentially. Reviews were analyzed 
and those that included appropriate data had their list of 
references hand-checked and, where possible, the original 
study was sourced for inclusion. If the original papers or 
reports were no longer available, or not available in English 
or for translation, the data presented in the review were in-
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Figure 1 Eastern Europe as subdivided into Northern (purple), 
Eastern (blue), Southern (green) and Western (red) regions, for 
the purposes of this review.V
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cluded, as was the case for Belarus and Turkey [4,5]. Lat-
vian, Bulgarian, Czech, Estonian, Slovak and Slovenian 
data were collected from the latest EU surveillance report 
by the latest surveillance report from the European Center 
for Disease Prevention and Control (ECDC) [6]. Due to the 
fact that the incidence of syphilis increased from 1990 but 
decreased markedly in most countries until a relative stag-
nation in 2004–2005, data from 2005 onwards were most 
sought after [2]. Only a single included study pre-dates this 
turning point, as no other single study was available for 
Turkey. Where multiple studies for the same country were 
available, the most recent data was used and the other stud-
ies were excluded. This search strategy returned 7 papers 
that provided data for inclusion, representing 13 countries.
Data extraction
Data extraction from the papers differed based on the in-
formation provided. The selected papers all reported either 
an incidence rate per 100 000 person-years or the number 
of cases notified at national level across a set time period, 
1–3 years for all included studies. In the event of case no-
tifications, this data was compared with the population 
data available from the World Bank for the year(s) in ques-
tion and this was extrapolated into an incidence rate [7]. 
Any study that directly reported an incidence rate had its 
population size analyzed using the same means and was 
then back transformed into a case notification rate. This al-
lowed more accurate approximation of the sub-regional 
disease burden.
RESULTS
Two of the studies included in this review were periodical 
surveillance reports – one at national level and the other at 
multinational level, providing case notifications and inci-
dence rates for each of the countries within the EU and 
European Free Trade Association (EFTA) [6,8]. Two re-
views were also included for analysis in this review [4,5]. 
The Turkish study was the only available data for the coun-
try and as such just met the inclusion criteria as the data 
were from 2000 [5]. The Belarusian review was focused on 
congenital syphilis; national data for all forms was also sup-
plied but without an original source paper that could be 
analyzed independently [4]. The remaining 3 included pa-
pers were case reports at a national level [9-11], which pro-
vided extractable data from which a national incidence 
could be inferred (Table 1, 2 and 3).
The Eastern European region has a wide variance of syph-
ilis incidence rates between its member countries based on 
the findings of this review (Figure 2). The maximum re-
ported was 41/100 000, as reported in Belarus in 2004 [4], 
and the minimum observed incidence was 1.15/100 000 
as reported in Albania in 2005 [9]. Thus, the ratio of these 
two most extreme incidences was 36:1, with a range be-
tween the values of 39.85 cases/100 000. The unweighted 
mean for the data was an incidence of 9.34/100 000, most 
similar to the situation in the Lithuania in 2009 [6]. The 
corresponding median value was 5.5/100 000, with the 
25th and 75th percentiles for the data being 4.2 and 7.3, 
Table 1 Non-standardised measures of syphilis incidence as they were reported in the studies included for analysis
reFerence country diSeaSe meaSurement non-StandardiSed value
Harxhi et al, 2010 [9] Albania Number of cases 37 cases
Pankratov et al. 2006 [4] Belarus Incidence rate 41 cases per 100 000
European Centre for Disease Control, 2011 [6] Bulgaria Cases and incidence rate 419 cases and 5.5 cases per 100 000
European Centre for Disease Control, 2011 [6] Czech Republic Cases and incidence rate 686 cases and 6.6 cases per 100 000
European Centre for Disease Control, 2011 [6] Estonia Cases and incidence rate 71 cases and 5.3 cases per 100 000
Ponyai et al., 2011 [10] Hungary Cases 2052 cases
European Centre for Disease Control, 2011 [6] Latvia Cases and incidence rate 223 cases and 10 cases per 100 000
European Centre for Disease Control, 2011 [6] Lithuania Cases and incidence rate 326 cases and 9.7 cases per 100 000
Majewski & Rudnicka, 2007 [11] Poland Incidence rate 2.46 cases per 100 000
Romanian Centre for prevention and control of communicable disease, 2008 [8] Romania Number of cases 4887 cases
European Centre for Disease Control, 2011 [6] Slovakia Cases and incidence rate 296 cases and 5.5 cases per 100 000
European Centre for Disease Control, 2011 [6] Slovenia Cases and incidence rate 47 cases and 2.3 cases per 100 000
Akturk et al., 2009 [5] Turkey Incidence rate 4.95 cases per 100 000
Table 2 Case definitions of syphilis cases from included studies
country caSe deFinition
Albania [9] Diagnosis of syphilis during time period leading to inclusion in national surveillance data
Belarus [4] From review paper, case definition given only as cases of syphilis per 100 000 population
Bulgaria [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Czech [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Estonia [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Hungary [10] Clinician diagnosis via direct detection of pathogens, results of serological tests and clinical picture
Latvia [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Lithuania [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Poland [11] Case reports referred to Public Health department
Romania [8] Cases detected from national screening procedures
Slovakia [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Slovenia [6] Diagnosis of syphilis during time period leading to inclusion in national and then EU surveillance data
Turkey [5] Diagnosis of syphilis during time period leading to inclusion in national surveillance dataV
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Table 3 Summary of included studies
country reFerence Study type Study time period Study location incidence rate 
(caSeS/100 000)
Albania Harxhi et al. 2010 [9] Case reports 1997-2005 Tirana, Albania 1.2
Belarus Pankratov et al. 2006 [4] Review 1996-2004 Belarus (National) 41.0
Bulgaria European Centre for Disease Control 2011 [6] Surveillance report 2009 Bulgaria (National) 5.5
Czech European Centre for Disease Control 2011 [6] Surveillance report 2009 Czech (National) 6.6
Estonia European Centre for Disease Control 2011 [6] Surveillance report 2009 Estonia(National) 4.2
Hungary Ponyai et al. 2010 [10] Case reports 2005 – 2008 Department of Dermatology,  
Venereology, Semmelweis University 5.1
Latvia European Centre for Disease Control 2011 [6] Surveillance report 2009 Latvia (National) 7.3
Lithuania European Centre for Disease Control 2011 [6] Surveillance report 2009 Lithuania (National) 9.7
Poland Majewski and Rudnicka 2007 [11] Case reports 2005-2006 Warsaw, Poland (National) 2.5
Romania Institutul de Sanatate Publica 2008 [8] Surveillance report 2007 Romania (National) 25.7
Slovakia European Centre for Disease Control 2011 [6] Surveillance report 2009 Slovakia (National) 5.5
Slovenia European Centre for Disease Control 2011 [6] Surveillance report 2009 Slovenia (National) 2.3
Turkey Asturk et al. 2001 [5] Surveillance review 1991-2000 Turkey (National) 5.0
respectively. Hence an interquartile range of 3.1 was ob-
served. From the collective data set the estimated un-
weighted burden of syphilis in Eastern Europe is 9.34 new 
cases per 100 000 population per year (95% confidence 
interval (CI) 2.50–16.19), which equates to 24 073 (95% 
CI 6441–41710) cases in 2011, based on the 257.63 mil-
lion people living in Eastern Europe at that time [7]. When 
the reported incidence rates were weighted against the to-
tal population at risk reported in the studies, the weighted 
mean for the regional burden of syphilis is 8.84 cases per 
100 000 person-years (Table 4).
For the proposed geographically subdivided estimate, the 
incidence rates of the Northern, Eastern, Southern and West-
ern regions were 7.85/100 000, 30.32/100 000, 4.85/100 000 
and 3.76/100 000 person-years, respectively. Using popula-
tion data to extrapolate the case notifications from this inci-
dence data, the geographically sub-divided estimate of case 
notifications is 32 597 cases in 2011, giving a geographical-
ly adjusted standardised rate of 12.65/100 000 person-years.
381 papers 
identified through 
database searches 
 
66 papers retained 
 
 
30 papers retained 
 
 
6 papers retained 
 
7 papers included  
315 papers excluded 
on the basis of title 
and/or abstract 
36 duplicate papers 
excluded 
 
24 papers excluded 
as data predated 
that of a country in 
another paper or 
paper unavailable 
for translation 
EU Surveillance 
report added 
 
Figure 2 Search strategy.
Table 4 Summary of results*
StatiStic value
Mean incidence 9.3/100 000  
(95% CI 2.50–16.19)
Median incidence 5.5/100 000
Maximum reported incidence 41.0/100 000
Minimum reported incidence 1.2/100 000
Max/min ratio 36:1
Range 39.9
25th percentile 4.2/100 000
75th percentile 7.3/100 000
Inter-quartile range 3.1
Weighted mean incidence 8.8/100 000
Geographically adjusted weighted mean 12.7/100 000
*Incidence is expressed in person-years, with 95% confidence (CI) interval.
DISCUSSION
Incidence rates have proven to be extremely heterogeneous 
across the 19 member states of the region, which was cap-
tured in the wide confidence interval around the unweight-
ed mean. The geographically divided weighted mean was 
carried out to approach this issue. However, ideally the data 
for each country would be included in such an estimate, 
thus negating the need to estimate incidences for large 
countries such as the Ukraine based around the previous 
incidence patterns of their neighboring countries. Further-
more, the inclusion of a 95% confidence interval around 
the weighted mean would have been preferable.
The heterogeneity in incidence rates could also in part be 
due to differences in population structure. The studies only 
reported cases or rates for whole populations without age-
group stratification. As all people are susceptible to syphi-
lis infection the entire population are included in calculat-
ing incidence rates, it is likely that age, sex and behavior 
all act as confounding variables for the presented estimates 
[2]. Countries with an aging population or high percentage 
of children would likely have lower syphilis rates than a 
population with a greater percentage of its citizens at their 
sexual peak. It is well documented that birth rates have de-
creased in Eastern Europe since the end of the USSR and 
this may account for some variation in the rates between V
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countries, but any further analysis of this issue was outside 
the scope of this review [2].
While EU surveillance data shows syphilis rates stabilizing 
post-2004, those countries outside the surveillance can be 
thought of as information gaps. One area of concern regard-
ing data accuracy is Belarus. The country has not embraced 
a unified European outloo like many of its neighbors. Con-
sequently, it is not included in the EU/EFTA surveillance 
data. The state of the health infrastructure is reflected in its 
reporting of the highest incidence rate. Belarusian syphilis 
rates reached their peak in 1996, with an incidence rate of 
209.7 cases per 100 000 person-years, compared to be-
tween 2 and 6 cases per 100 000 in Poland, Hungary and 
the Czech Republic [2]. As the data included in this study 
is from 2004, this rate may not be representative of the true 
incidence rate anymore. Similar assumptions could be as-
signed to the estimated incidence in the Ukraine.
A suggestion for future research would be to conduct epi-
demiological surveillance into the incidence of syphilis in 
the countries of the former Soviet Union. The most recent 
review of syphilis in Eastern Europe stated that the inci-
dence rate of syphilis within the Russian Federation was 
>50 cases per 100 000 person-years in 2005 [2]. Another 
review into the incidence of HIV and syphilis in Central 
Asian countries was carried out in 2003, returning inci-
dence rates for 2002 of 122, 55, 12.7 and 25.8 per 100 000 
person-years in Kazakhstan, Kyrgyzstan, Tajikistan and Uz-
bekistan, respectively [12]. Such high incidence rates are 
indicative that these countries experienced the same epi-
demics of sexually transmitted infections (STI) which fol-
lowed the collapse of the Soviet Union in other countries. 
From this data it can be seen that the incidence rates with-
in the former Soviet Union are generally higher than for 
non-Soviet Eastern European countries, although the 
North-Eastern European region returned incidences closer 
to their EU neighbors. Reasons for this may include chang-
ing demography and migration patterns within the region, 
eg, more young people migrating to cities to search for em-
ployment. It should be noted that the Central Asian data 
are now 10 years old and as syphilis rates in Eastern Eu-
rope have decreased substantially during this period, and 
so may have the Central Asian rates. However, this is still 
an avenue open to further research, as comprehensive data 
on the topic is sparse and analysis of trends may aid con-
trol and prevention efforts.
Of the papers retrieved from our literature search, several 
were regional estimates of syphilis incidence at a city or 
provincial level. While this review only included national 
estimates, it is important to note that regional studies are 
not always reflective of incidence rates at national level. 
Other studies have shown previously that syphilis rates can 
vary greatly within the provinces of a country [13] and the 
findings of this review concur with this assessment. An ex-
ample of this is Czech Republic in 2009. Our literature 
search returned a paper that provided case notification data 
from a regional surveillance conducted in the Prague met-
ropolitan area [14]. Population data for this region was 
sourced from the Czech Department of Statistics and the 
case notifications were transformed into an incidence rate 
for the region using this data [15]. The EU national surveil-
lance rate and the regional rate were 6.6 and 10.8 cases per 
100 000 person-years, respectively. As such, the regional 
estimate returned an incidence rate was 1.6 times that of 
the national estimate. Thus, future reviews into the burden 
of syphilis should be wary of including regional data as re-
gional estimates may confound their results. A possible ex-
planation for such a difference between the estimates is the 
demography of region. Prague, being the country's capital, 
hub of tourism and economic center may vary significant-
ly from other regions in the density of subpopulations in-
cluding men who have sex with men, sex workers and 
people in their sexual peak.
A comparison of the 2009 ECDC surveillance report data 
for the 5 included countries with that for 2006 shows di-
verging patterns in syphilis trends. It is noted by the ECDC 
itself that there is likely to be significant under reporting of 
cases and there is varying quality in the surveillance net-
works in each country. In Slovenia, for example, reporting 
is carried out by physicians with no laboratory or hospital 
reporting [6]. The 3 countries for which there was a large 
percentage increase have typically exhibited year on year 
increase since 2006, which cannot be attributed to either 
increase in syphilis incidence, or increased surveillance ca-
pability, without more in depth understanding of the de-
velopment of syphilis reporting system in each country. 
Furthermore, there is no way to determine how accurate 
the reporting is for private health services. Ultimately, sur-
veillance accuracy will be dependent on the countries 
health care infrastructure and as such surveillance data 
from the less affluent countries should be viewed with cau-
tion. When assessing the included literature as a whole, the 
case definitions for syphilis were not explicit for many stud-
ies. This introduces the probability of diagnostic misclas-
sification bias, especially when considered alongside the 
poor access to diagnostic technology in several countries. 
It can be assumed that not all cases were subjected to Trepo-
nema testing, serology or dark field microscopy to identify 
the bacteria, thus diagnoses may have been made purely 
on clinical presentation or non-treponemal tests, many of 
which have well documented specificity issues [16-19]. 
Random misdiagnoses, while problematic, would not be as 
damaging to the data’s validity as systematic misdiagnosis 
based on altered clinical presentation due to co-infection 
with HIV for example, which has been the subject of sev-
eral other studies [16-17].V
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CONCLUSIONS
The incidence of syphilis in the EU 15 countries was 
2.78/100 000 in 2007 [6]. When compared to our geo-
graphically subdivided estimate of 12.51/100 000 for the 
Eastern Europe, this highlights the great disparity in the 
control of sexually transmitted infections between the re-
gions. Healthcare planning must strengthen treatment op-
tions for HIV and syphilis, as both diseases act as risk fac-
tors for each other. Reductions in HIV prevalence are 
likely to have a beneficial effect on syphilis prevalence and 
outcomes. However, syphilis infection increases chances of 
HIV transmission by 7 times and thus treatment can be 
seen as a way to reduce HIV prevalence in high risk groups 
[17]. Possible incentives for progress in this area are com-
mitments to the UN Millennium Development Goals, of 
which HIV reduction and reducing child mortality, in this 
case due to congenital syphilis, are both included [17].
Investing in health infrastructure and surveillance capabil-
ity would strengthen the control of syphilis. Increased 
knowledge of transmission dynamics would allow target-
ing of specific regions or subpopulations where the burden 
of disease is higher. One area that health policy research in 
Eastern Europe should address is transparency in the state 
of health provision and the percentage of health care pro-
vided by private services. Previous reviews have highlight-
ed the impact of these services on STI control, but have 
been unable to quantify their effect [2]. Thus, this can be 
considered a confounder to available disease estimates in-
cluding the ECDCs surveillance [6].
Current opinion suggests funding should be focused on ex-
tending the availability and efficacy of the rapid Treponema 
tests [18,19] and the extension of education programs [20]. 
Enhancement of the availability of rapid testing would re-
duce the reliance on more traditional serological and micros-
copy methods. Those traditional methods require transport 
of blood to centralised facilities and the maintenance of a 
“cold chain” to ensure validity of the test [19]. Furthermore, 
vaccine development from its current stage of testing in rab-
bit models should receive support, because mass vaccination 
campaigns have the potential to significantly to reduce the 
transmission potential of syphilis [19].
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